Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases
Buyer: Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
- Published
- 17 March 2026
- Estimated value
- €244,000,000
- Lots
- 1
- Notice number
- 00183038-2026
- Official source
- Official source
CPV codes
- 73000000Servicios de investigación y desarrollo y servicios de consultoría conexos
Description
This call for tenders aims at speeding up the development of promising Next Generation Therapeutics for Infectious Diseases by adopting a competitive development in phases, under Pre-Commercial Procurement (PCP). The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, ARDS or sepsis resulting from infections, including pathogen-targeted therapeutics (but not small molecules or monoclonal antibodies) and host-targeted therapeutics, among which but not only direct-acting antivirals, indirect-acting antivirals and novel immune modulators. It may also cover innovative combinations therapies and products designed to be administered through alternative routes to IV. Broad spectrum therapeutics, pathogen-agnostic therapeutics and therapeutics that could reduce or counteract the emergence of viral resistance are of particular interest.
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €244,000,000.
- Who is the buyer of this tender?
- The contracting authority is Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency (European Union).
Create a free account and receive new tenders from European Union matching your business, every day.